Literature DB >> 30814823

Altered Micro-RNA Regulation and Neuroprotection Activity of Eremostachys labiosiformis in Alzheimer's Disease Model.

Mohammad Rasoul Samandari-Bahraseman1, Mehrdad Jahanshahi2, Sara Asadi Barbariha3, Leila Elyasi2.   

Abstract

BACKGROUND: Amyloid-β peptide (Aβ) is involved in the formation of senile plaques in Alzheimer's disease (AD), and causes neuronal cell death by inducing oxidative stress.
OBJECTIVE: We investigated the protective effect of Eremostachys labiosiformis extract against the Aβ-induced toxicity in SH-SY5Y cells.
METHODS: Methanolic extract from the aerial parts of E. labiosiformis was prepared by percolation method at room temperature. SH-SY5Y cells were treated and incubated with different concentrations of the extract for 1 h, before addition of Aβ. Cytotoxicity was measured 24 h after the addition of Aβ to the medium using MTT and reactive oxygen species (ROS) assays. Effective doses were evaluated using real-time polymerase chain reaction to evaluate expression of miR-212 and miR-132. The results were analyzed using SPSS software (16).
RESULTS: Exposure of -SH-SY5Y cells to Aβ significantly affected the viability of cells and increased ROS levels. The results revealed that 1.2 and 2.5 μg/mL of the E. labiosiformis extract reduced Aβ-induced deterioration. Only 2.5 μg/mL of the extract could reduce ROS levels. In addition, 5 μg/mL of the extract increased the expression of the miRNAs, which was reduced after exposure to Aβ.
CONCLUSION: Based on the antioxidant and protective effects of the E. labiosiformis extract on expression of miR-132 and miR-212 and ROS level, this herb could be used as a suitable candidate for future studies on neurodegenerative diseases including AD.

Entities:  

Keywords:  Alzheimer's disease; Amyloid beta; Apoptosis; Eremostachys labiosiformis

Year:  2018        PMID: 30814823      PMCID: PMC6388430          DOI: 10.1159/000489551

Source DB:  PubMed          Journal:  Ann Neurosci        ISSN: 0972-7531


  17 in total

Review 1.  The role of phytochemicals in the treatment and prevention of dementia.

Authors:  Melanie-Jayne R Howes; Elaine Perry
Journal:  Drugs Aging       Date:  2011-06-01       Impact factor: 3.923

Review 2.  Cancer chemoprevention with dietary phytochemicals.

Authors:  Young-Joon Surh
Journal:  Nat Rev Cancer       Date:  2003-10       Impact factor: 60.716

Review 3.  Biological functions of microRNAs: a review.

Authors:  Yong Huang; Xing Jia Shen; Quan Zou; Sheng Peng Wang; Shun Ming Tang; Guo Zheng Zhang
Journal:  J Physiol Biochem       Date:  2010-10-28       Impact factor: 4.158

Review 4.  MicroRNAs in Alzheimer's disease.

Authors:  Charlotte Delay; Wim Mandemakers; Sébastien S Hébert
Journal:  Neurobiol Dis       Date:  2012-01-17       Impact factor: 5.996

Review 5.  Alzheimer mechanisms and therapeutic strategies.

Authors:  Yadong Huang; Lennart Mucke
Journal:  Cell       Date:  2012-03-16       Impact factor: 41.582

Review 6.  The role of oxidative stress in the toxicity induced by amyloid beta-peptide in Alzheimer's disease.

Authors:  S Miranda; C Opazo; L F Larrondo; F J Muñoz; F Ruiz; F Leighton; N C Inestrosa
Journal:  Prog Neurobiol       Date:  2000-12       Impact factor: 11.685

Review 7.  Inflammation, microglia, and Alzheimer's disease.

Authors:  Brent Cameron; Gary E Landreth
Journal:  Neurobiol Dis       Date:  2009-10-13       Impact factor: 5.996

Review 8.  Natural antioxidants in Alzheimer's disease.

Authors:  Cesare Mancuso; Timothy E Bates; D Allan Butterfield; Stella Calafato; Carolin Cornelius; Antonino De Lorenzo; Albena T Dinkova Kostova; Vittorio Calabrese
Journal:  Expert Opin Investig Drugs       Date:  2007-12       Impact factor: 6.206

Review 9.  Inflammation, apoptosis, and Alzheimer's disease.

Authors:  Maria E Bamberger; Gary E Landreth
Journal:  Neuroscientist       Date:  2002-06       Impact factor: 7.519

10.  MicroRNA: Implications for Alzheimer Disease and other Human CNS Disorders.

Authors:  Olivier C Maes; Howard M Chertkow; Eugenia Wang; Hyman M Schipper
Journal:  Curr Genomics       Date:  2009-05       Impact factor: 2.236

View more
  1 in total

Review 1.  Alzheimer's Disease and microRNA-132: A Widespread Pathological Factor and Potential Therapeutic Target.

Authors:  Meng Zhang; Zhigang Bian
Journal:  Front Neurosci       Date:  2021-05-24       Impact factor: 4.677

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.